“…Owing to its mild and broad therapeutic efficacy, tanshinone IIA (TSA), a major component extracted from the traditional herbal Chinese medicine Salvia miltiorrhiza Bunge , has been widely studied for its various biological activities, including antiangiogenic (Zhou, Sui, et al., 2020), antioxidant (Fu et al., 2007), anti‐inflammatory (Jang et al., 2003), anti‐cancer properties (Chiu & Su, 2010), neuron‐protective (Wang et al., 2018), anti‐atherosclerotic (Tan et al., 2019), antiallergic (Heo & Im, 2019), anticonvulsant (Buenafe et al., 2013), anti‐Alzheimer's disease (Li et al., 2015), reducing organ damage (Ma et al., 2018), attenuating polycystic ovarian syndrome (Jin et al., 2019), suppression of ovarian cancer growth (Zhou, Jiang, et al., 2020), and protection from angina pectoris and myocardial infarction (Lv et al., 2018). Various pre‐clinical and clinical studies have asserted the role of TSA in targeting tumour cells.…”